BlackRock Institutional Trust’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

BlackRock Institutional Trust’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$118K	Buy	29,128 +23,389	+408%	+$109K	﹤0.01%	3643
2016 Q3	$42K	Hold	5,739	–	–	﹤0.01%	3763
2016 Q2	$29K	Sell	5,739 -4,251	-43%	-$78.3K	﹤0.01%	3794
2016 Q1	$215K	Sell	9,990 -1,753	-15%	-$37.1K	﹤0.01%	3622
2015 Q4	$359K	Buy	11,743 +10,513	+855%	+$308K	﹤0.01%	3558
2015 Q3	$41K	Buy	+1,230	New	+$69.4K	﹤0.01%	3830
2015 Q2	–	Sell	-397	Closed	-$14K	–	3972
2015 Q1	$14K	Buy	+397	New	+$17.4K	﹤0.01%	3812

Other funds holding MRNS

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BlackRock Institutional Trust's MRNS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Marinus Pharmaceuticals, Inc (MRNS) stake by 408% in Q4 2016, buying an estimated $109K and bringing the position to 29,128 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #3643.

BlackRock Institutional Trust first reported a position in MRNS in Q1 2015 and has held it in 7 quarters since. The position peaked at $359K in Q4 2015. 23 funds tracked by Wall St. Rank hold MRNS as of Q4 2016.

BlackRock Institutional Trust held 29,128 shares of Marinus Pharmaceuticals, Inc worth $118K as of Q4 2016.
BlackRock Institutional Trust bought 23,389 Marinus Pharmaceuticals, Inc shares in Q4 2016, an estimated $109K.
Marinus Pharmaceuticals, Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3643 holding.
BlackRock Institutional Trust first reported a position in Marinus Pharmaceuticals, Inc in Q1 2015 and has held it in 7 quarters since.
BlackRock Institutional Trust's Marinus Pharmaceuticals, Inc position peaked at $359K in Q4 2015.
23 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.